Philip Gorelick
Professor of Translational Science and Molecular Medicine
Expert in stroke prevention and risk factor identification.
Get in touchBiography
Philip B. Gorelick is a professor of translational science and molecular medicine at MSU and the emeritus medical director of the Hauenstein Neuroscience Center at Saint Mary’s Health Care in Grand Rapids, Michigan.
His work is centered around stroke prevention and identifying risk factors.
Gorelick has received nearly $40 million in research funding from the National Institutes of Health and has helped lead a clinical trial studying a new clot-busting drug for strokes. He has also worked with
...
the American Heart Association offering guidance on preventing cognitive impairment and dementia by controlling risk factors for cardiovascular disease.
Education
Loyola University Chicago Stritch School of Medicine: MD, Medicine | 1997
Selected Press
AHA/ASA: Heart-healthy lifestyle also benefits brain health
Cardiology Today | 2017-09-01
"“Research summarized in the advisory convincingly demonstrates that the same risk factors that cause atherosclerosis are also major contributors to late-life cognitive impairment and Alzheimer’s disease,” Philip B. Gorelick, MD, MPH, FAHA, executive medical director of Mercy Health Hauenstein Neurosciences in Grand Rapids, Michigan, and the chair of the advisory’s writing group, said in a press release. “By following seven simple steps — Life’s Simple 7 — not only can we prevent heart attack and stroke, we may also be able to prevent cognitive impairment..."